Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
42.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (2.381%)
Market Cap: £81.54m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Board Appointment

16 Aug 2013 07:00

RNS Number : 8287L
Iofina PLC
16 August 2013
 



16 August 2013

 

Iofina plc

("Iofina" or the "Company")

(LSE AIM: IOF)

 

Board Appointment

 

Iofina, specialists in the exploration and production of iodine and iodine specialty chemical derivatives, is pleased to announce the appointment of Mr Gary Dale Gatchell as an Executive Director to the Board. Gary will also serve as the Company's Finance Director with effect from September 3, 2013.

 

Gary (56) has a demonstrable twenty five year track record of financial experience and expertise. Most recently Gary was Chief Finance Officer of NASDAQ listed Ascent Solar Technologies, Inc. ("Ascent Solar").

 

Gary brings to Iofina a strong background in public company financial reporting and internal controls. He also has experience with private and public capital funding, as well as merger and acquisition activity on both the buy-side and sell-side.

 

From 2005 to 2008, he served as the Chief Financial Officer of Carrier Access Corporation ("Carrier Access"), a telecommunications equipment provider, to reorganise finance and administration infrastructure. Prior to joining Carrier Access, Gary was part of the original founding management team of Voyant Technologies, Inc. ("Voyant"), a leading provider of audio conferencing equipment that was subsequently acquired by Polycom, Inc. Serving as Chief Financial Officer he helped grow Voyant from eight employees to over two hundred, enabling a return of 20x to Voyant's Series A investors, after only four years. A previous audit manager at KPMG, Gary is a registered Certified Public Accountant and has a Master's degree in Accountancy from the University of Denver. 

The Company's current Finance Director, Michael Coddington, will remain with the Company as Chief Financial Officer of Iofina Chemical, Inc., allowing him to focus on the growth and financial aspects of this division. Michael has done an excellent job for the Company during his tenure as Finance Director. As was always planned, once the Company established itself as a key player in the iodine market, strengthening of the Company's financial team was envisioned to ensure rapid growth, good corporate governance and balance the workload across a sound financial management team of which Michael will be a key part.

Commenting on the appointment Dr. Chris Fay, Executive Chairman, said ''We are very pleased to welcome Gary to the Board at a very exciting time in the Company's development. Gary has extensive financial management experience that will be important as Finance Director in order to maximise this exciting rapid time of growth and profitability. The Board would like to thank Michael for his support to date and looks forward to working with him in the future"

 

Save as set out below there is no further information required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules:

 

Current Directorships:

Directorships in past 5 years

Colorado Advanced Manufacturing Alliance

 

 

 

For further information, please contact:

 

Dr. Chris Fay, Executive Chairman

Iofina plc

Tel: +44(0)20 3006 3135

www.iofina.com

 

Ben Colegrave/Chris Sim/James Rudd

Investec

Tel: +44(0)20 7597 5970

 

Media Contact:

Dominic Barretto

Yellow Jersey PR Limited

Tel: +44(0) 7768 537 739

 

About Iofina

 

Iofina specializes in the exploration and production of iodine, iodine specialty chemical derivatives, produced water and natural gas. Iofina's business strategy is to identify, develop, build, own and operate iodine extraction plants currently focused in North America based on Iofina's WET® IOsorb™ technology. Iofina has iodine production operations in the United States, specifically in Texas, California, Montana, Oklahoma and Wyoming. The Group has complete vertical integration from the production of iodine in the field to the manufacture of the chemical end products derived from iodine to the consumer and the recycling of iodine using iodinated side-streams from waste chemical processes in Europe, North America and Asia. The Group utilizes its portfolio of patented and patent pending technology, proprietary methods and trademarks throughout all business lines.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGMRKKRGFZM
Date   Source Headline
5th Jun 20267:00 amRNSAgreement Signed for Additional Brine Water Supply
5th May 20267:00 amRNSNotice of AGM
30th Apr 20264:45 pmRNSHolding(s) in Company
30th Apr 202611:30 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSFinal Results
16th Apr 20261:40 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSQ1 2026 Corporate Update
20th Mar 202612:25 pmRNSHolding(s) in Company
13th Jan 20267:00 amRNSQ4 2025 Corporate Update
6th Jan 20267:00 amRNSHolding(s) in Company
12th Dec 20257:00 amRNSDirectorate change
5th Dec 20257:00 amRNSAgreement with Western Midstream
12th Nov 20258:15 amRNSHolding(s) in Company
16th Oct 20257:00 amRNSQ3 2025 Update
3rd Oct 20253:32 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSInterim Results
4th Sep 20257:00 amRNSBusiness Update
17th Jul 20257:00 amRNSH1 2025 Update
9th Jul 20257:00 amRNSCapital Reduction
9th Jun 20255:00 pmRNSResult of AGM
14th May 20257:00 amRNSNotice of AGM and Proposed Capital Reduction
12th May 20257:00 amRNS-RInvestor Presentation
12th May 20257:00 amRNSFinal Results
25th Apr 20253:45 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 2025 Update
23rd Jan 20257:00 amRNSQ4 2024 Update
18th Dec 20244:45 pmRNSHolding(s) in Company
21st Oct 20247:00 amRNSHolding(s) in Company
18th Oct 20247:00 amRNSQ3 2024 Update
27th Sep 20247:00 amRNSIO#11 Update
20th Sep 20247:00 amRNSInterim Results
13th Sep 20247:00 amRNSIO#10 Iodine Plant Commissioned
16th Jul 20247:00 amRNSH1 Update
27th Jun 202411:04 amRNSHolding(s) in Company
25th Jun 20247:00 amRNSHolding(s) in Company
13th Jun 20241:00 pmRNSResult of AGM
29th May 20244:50 pmRNSLaunch of new website
15th May 20247:00 amRNSNotice of AGM and Resignation of Director
2nd May 20247:00 amRNSFinal Results
16th Apr 20247:00 amRNSQ1 2024 Corporate Update
17th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSQ4 2023 Corporate Update
30th Nov 20237:00 amRNSIO#9 Update
20th Oct 20237:00 amRNSSigned Agreement for IO#10 and Q3 2023 Update
11th Sep 20237:00 amRNSInterim Results
25th Aug 20235:00 pmRNSHolding(s) in Company
24th Jul 20235:00 pmRNSHolding(s) in Company
20th Jul 20237:00 amRNSH1 Update and Updated Loan Facilities
14th Jun 20232:00 pmRNSResult of AGM
14th Jun 20237:00 amRNSIO#9 Iodine Plant Operating

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.